VF
ANAB icon

Virtu Financial’s AnaptysBio ANAB Stock Holding History

Virtu Financial’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,323
Closed -$1.85M – 1567
2026
Q1 		$1.85M Buy
+33,323
New +$1.79M 0.08% 169
2025
Q4 		– Sell
-15,531
Closed -$476K – 1624
2025
Q3 		$476K Buy
+15,531
New +$356K 0.03% 581
2024
Q2 		– Sell
-9,850
Closed -$222K – 1271
2024
Q1 		$222K Buy
+9,850
New +$233K 0.02% 742
2018
Q1 		– Sell
-2,923
Closed -$294K – 1913
2017
Q4 		$294K Sell
2,923
-5,584
-66% -$411K 0.02% 1288
2017
Q3 		$297K Buy
+8,507
New +$229K 0.01% 1392

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Virtu Financial's ANAB Position: Q2 2026 in Review

Virtu Financial sold out of AnaptysBio (ANAB) in Q2 2026, closing a stake of 33,323 shares — an estimated $1.85M sold.

Virtu Financial first reported a position in ANAB in Q3 2017 and held it in 5 quarters. The position peaked at $1.85M in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Virtu Financial reported no remaining AnaptysBio position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 33,323 AnaptysBio shares in Q2 2026, an estimated $1.85M.
  • Virtu Financial first reported a position in AnaptysBio in Q3 2017 and held it in 5 quarters.
  • Virtu Financial's AnaptysBio position peaked at $1.85M in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.